Antibodies to coronavirus were detected in the second group of volunteers who participated in vaccine trials at the Main Military Clinical Hospital named after N. N. Burdenko. This was announced on Monday by the head of the 48th Central Research Institute of Radiation, Chemical and Biological Defense Troops (RHBZ) of the RF Armed Forces, Colonel of the Medical Service Sergei Borisevich.
"The available test data confirm that as a result of vaccination, the volunteers have identified the necessary antibodies to coronavirus, and the vaccine components are safe and well tolerated by humans," Borisevich said in an interview with the Krasnaya Zvezda newspaper.